Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Neurofilaments

Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer’s disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer’s disease.

Due to the similarity of the symptoms, differentiating patients with Alzheimer’s from those… Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease   



Enid and George - Life with dementia

dementia community1 - moderate dementia1 - dsm-51 - brain insulin1 - coping strategies1 - mayo clinic1 - cognitive decline19 - amyloid beta precursor protein1 - pre-dementia stage1 - alzheimer's symptoms2 - atherosclerotic plaques2 - irreversible dementia syndrome1 - non-familial parkinson's1 - tia2 - memory losses1 - virtual reality1 - knopman1 - fish oil supplements1 - ipscs1 - dementia care4 - decline in memory1 - medium spiny neurons1 - cognitive dysfunction4 - alzheimer's signs1 - wernicke’s encephalopathy1 - mild traumatic brain injury1 - micro-gliosis1 - carl schneider1 - stroke risk factors1 - parkinson's patients5 -